Belite Bio, Inc. · NASDAQ:BLTE

Scholl Hendrik Peter sold 2,000 Belite Bio, Inc. shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 16, 2026

On Nov 12, 2026, Scholl Hendrik Peter (Chief Medical Officer) sold 2,000 Belite Bio, Inc. shares at an average US$165.99 for US$332K under a trading plan, leaving 12,500 shares. Filed Nov 16, 2026 (Form 4).

Sold
2,000 shares
Price
US$165.99 average (US$162.04 to US$170.41)
Value
US$332K
Holding after
12,500 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026American depositary shareSale500US$162.0414,000Indirect
Nov 12, 2026American depositary shareSale500US$164.6813,500Indirect
Nov 12, 2026American depositary shareSale500US$166.8213,000Indirect
Nov 12, 2026American depositary shareSale500US$170.4112,500Indirect

Source

Download original · View original at SEC

Related